During the past decade, Oakland Ophthalmic Surgery conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oakland Ophthalmic Surgery" are "Cataract" (3 trials), "Corneal Astigmatism" (2 trials) and "Non-infectious Anterior Uveitis" (2 trials). Many other conditions were trialed in "Oakland Ophthalmic Surgery" in a lesser frequency.

Most popular intervention types in "Oakland Ophthalmic Surgery" are "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ADX-102 Ophthalmic Solution (0.5%)" (1 trials), "Higher Cylinder Toric IOL" (1 trials), "Lower Cylinder Toric IOL" (1 trials), "NS2" (1 trials) and "Prednisolone acetate ophthalmic suspension (1%)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oakland Ophthalmic Surgery" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Oakland Ophthalmic Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Oakland Ophthalmic Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oakland Ophthalmic Surgery, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".